Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• SuhDHKimMMajor clinical research advances in gynecologic cancer in 2015J Gynecol Oncol2016276e5327775259
   PubMedGoogle Scholar
• MillsKFuhKRecent advances in understanding, diagnosing, and treating ovarian cancerF1000Research201768428184293
   PubMedGoogle Scholar
• BaiHCaoDYangJLiMZhangZShenKGenetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapyJ Cell Mol Med201620458159326800494
   PubMed Web of Science ®Google Scholar
• PrasetyantiPRMedemaJPIntra-tumor heterogeneity from a cancer stem cell perspectiveMol Cancer20171614128209166
   PubMedGoogle Scholar
• OzakpinarOBMaurerAMOzsavciDOvarian stem cells: from basic to clinical applicationsWorld J Stem Cells20157475776826029346
   PubMed Web of Science ®Google Scholar
• RenFShenJShiHHornicekFJKanQDuanZNovel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancerBiochim Biophys Acta20161866226627527717733
   PubMed Web of Science ®Google Scholar
• Walters HaygoodCLArendRCStraughnJMBuchsbaumDJOvarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?World J Stem Cells20146444144725258665
   PubMedGoogle Scholar
• TomaoFPapaAStrudelMInvestigating molecular profiles of ovarian cancer: an update on cancer stem cellsJ Cancer20145530131024723972
   PubMedGoogle Scholar
• ChenXZhangJZhangZLiHChengWLiuJCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaHum Pathol201344112373238423850493
   PubMed Web of Science ®Google Scholar
• ThapaRWilsonGDThe importance of CD44 as a stem cell biomarker and therapeutic target in cancerStem Cells Int20162016208720427200096
   PubMed Web of Science ®Google Scholar
• SchmohlJUValleraDACD133, selectively targeting the root of cancerToxins (Basel)201686 pii: E165
   PubMedGoogle Scholar
• MiettinenMLasotaJKIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlationAppl Immunohistochem Mol Morphol200513320522016082245
   PubMedGoogle Scholar
• ZhaoFChenYWuQWangZLuJPrognostic value of CD117 in cancer: a meta-analysisInt J Clin Exp Pathol2014731012102124696718
   PubMed Web of Science ®Google Scholar
• GiuscaSECaruntuIDCimpeanAMTryptase-positive and CD117 positive mast cells correlate with survival in patients with liver metastasisAnticancer Res201535105325533126408693
   PubMedGoogle Scholar
• ZhangSBalchCChanMWIdentification and characterization of ovarian cancer-initiating cells from primary human tumorsCancer Res200868114311432018519691
   PubMed Web of Science ®Google Scholar
• YanHCFangLSXuJThe identification of the biological characteristics of human ovarian cancer stem cellsEur Rev Med Pharmacol Sci201418223497350325491627
   PubMed Web of Science ®Google Scholar
• ConicIStanojevicZJankovic VelickovicLEpithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapyJ Obstet Gynaecol Res201541101630163726177978
   PubMedGoogle Scholar
• Stemberger-PapicSVrdoljak-MozeticDOstojicDVExpression of CD133 and CD117 in 64 serous ovarian cancer casesColl Antropol201539374575326898076
   PubMedGoogle Scholar
• AyubTHKeyver-PaikMDDebaldMAccumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancerOncotarget2015618164371644825999351
   PubMed Web of Science ®Google Scholar
• TonaryAMMacdonaldEAFaughtWSentermanMKVanderhydenBCLack of expression of c-KIT in ovarian cancers is associated with poor prognosisInt J Cancer200089324225010861500
   PubMedGoogle Scholar
• HuangRWuDYuanYCD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patientsPloS One2014911e11220925380303
   PubMedGoogle Scholar
• LassusHSihtoHLeminenAGenetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinomaBr J Cancer200491122048205515583695
   PubMedGoogle Scholar
• BrustmannHImmunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic studyGynecol Oncol200598339640216005054
   PubMedGoogle Scholar
• KhalifehIMunkarahARSchimpVMorrisRLawrenceWDAli-FehmiRThe impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinomaInt J Gynecol Pathol200524322823415968197
   PubMedGoogle Scholar
• ZhouQChenASongHTaoJYangHZuoMPrognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysisI Int J Clin Exp Med2015833080308826064196
   PubMed Web of Science ®Google Scholar
• LinJDingDThe prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysisCancer Cell Int201717828070170
   PubMed Web of Science ®Google Scholar
• LuoLZengJLiangBOvarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcomeExp Mol Pathol201191259660221787767
   PubMedGoogle Scholar
• ZhangRZhangPWangHInhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+) CD117(+) ovarian cancer stem cellsStem Cell Res Ther2015626226718286
   PubMed Web of Science ®Google Scholar
• CaoLShaoMSchilderJGuiseTMohammadKSMateiDTissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancerOncogene201231202521253421963846
   PubMed Web of Science ®Google Scholar
• CheneGOuelletVRahimiKExpression of stem cell markers in preinvasive tubal lesions of ovarian carcinomaBiomed Res Int2015201580853126504831
   PubMedGoogle Scholar
• LiuSLiuCMinXPrognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysisPloS One2013811e8105024282568
   PubMedGoogle Scholar
• LiLNZhouXGuYYanJPrognostic value of MMP-9 in ovarian cancer: a meta-analysisAsian Pac J Cancer Prev20131474107411323991961
   PubMedGoogle Scholar
• DengJWangLChenHTargeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancerOncotarget2016734557715578827304054
   PubMedGoogle Scholar
• WangXLiXFuXEliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistanceCurr Protein Pept Sci201516427027825929861
   PubMedGoogle Scholar